MassIVE MSV000087654

Complete Public

Secreted retrovirus-like GAG domain containing protein PEG10 is regulated by UBE3A and is involved in Angelman syndrome pathophysiology

Description

Angelman syndrome (AS) is a severe neurodevelopmental disorder caused by mutations that effect expression of the maternal UBE3A allele, which encodes the ubiquitin protein ligase E3A (UBE3A). Although several potential UBE3A targets have been identified, our understanding of relevant disease targets is very limited, and validation in patient-derived cells is lacking. We established human iPSC (hiPSC) control and AS patient-derived neuronal models and demonstrate specific and reciprocal modulation of UBE3A using anti-sense oligonucleotides (ASOs). Through unbiased proteomic analysis we identified proteins whose abundance were directly affected by manipulating UBE3A levels, including the novel human specific PEG10 protein, a secreted retrotransposon derived GAG domain-containing protein. PEG10 protein, but not RNA, was elevated in AS hiPSC-derived neurons as well as in postmortem AS brain tissue, and we showed that its upregulation in patient-derived cells is dependent on both UBE3A and normal proteasome function. Functional analysis revealed that PEG10 binds both RNA and ataxia associated proteins, ATXN2 and ATXN10. PEG10 localizes to stress granules and is secreted in extracellular vesicles, where it regulates vesicle content. AS patient-derived neurons in which either UBE3A was reinstated or PEG10 was reduced, showed a striking similarity in transcriptome changes. In addition, overexpression of PEG10 during mouse brain development affected the migration of the PEG10-overexpressing neurons, suggesting that PEG10 overexpression can affect neuronal function at a critical time during brain development. Taken together these findings imply that PEG10 is a novel secreted UBE3A target, and is involved in AS pathophysiology. [doi:10.25345/C5VV65] [dataset license: CC0 1.0 Universal (CC0 1.0)]

Keywords: hiPSC neurons ; Retroviral GAG ; RNA binding protein ; Stress granules ; Extracellular vesicles

Contact

Principal Investigators:
(in alphabetical order)
Nikhil J. Pandya, Roche Innovation Center Basel, F. Hoffmann-La Roche Ltd, Switzerland
Submitting User: manueltz
Number of Files:
Total Size:
Spectra:
Subscribers:
 
Owner Reanalyses
Experimental Design
    Conditions:
    Biological Replicates:
    Technical Replicates:
 
Identification Results
    Proteins (Human, Remapped):
    Proteins (Reported):
    Peptides:
    Variant Peptides:
    PSMs:
 
Quantification Results
    Differential Proteins:
    Quantified Proteins:
 
Browse Dataset Files Browse Results
 
FTP Download Link (click to copy):

- Dataset Reanalyses


+ Dataset History


Click here to queue conversion of this dataset's submitted spectrum files to open formats (e.g. mzML). This process may take some time.

When complete, the converted files will be available in the "ccms_peak" subdirectory of the dataset's FTP space (accessible via the "FTP Download" link to the right).
Number of distinct conditions across all analyses (original submission and reanalyses) associated with this dataset.

Distinct condition labels are counted across all files submitted in the "Metadata" category having a "Condition" column in this dataset.

"N/A" means no results of this type were submitted.
Number of distinct biological replicates across all analyses (original submission and reanalyses) associated with this dataset.

Distinct replicate labels are counted across all files submitted in the "Metadata" category having a "BioReplicate" or "Replicate" column in this dataset.

"N/A" means no results of this type were submitted.
Number of distinct technical replicates across all analyses (original submission and reanalyses) associated with this dataset.

The technical replicate count is defined as the maximum number of times any one distinct combination of condition and biological replicate was analyzed across all files submitted in the "Metadata" category. In the case of fractionated experiments, only the first fraction is considered.

"N/A" means no results of this type were submitted.
Originally identified proteins that were automatically remapped by MassIVE to proteins in the SwissProt human reference database.

"N/A" means no results of this type were submitted.
Number of distinct protein accessions reported across all analyses (original submission and reanalyses) associated with this dataset.

"N/A" means no results of this type were submitted.
Number of distinct unmodified peptide sequences reported across all analyses (original submission and reanalyses) associated with this dataset.

"N/A" means no results of this type were submitted.
Number of distinct peptide sequences (including modified variants or peptidoforms) reported across all analyses (original submission and reanalyses) associated with this dataset.

"N/A" means no results of this type were submitted.
Total number of peptide-spectrum matches (i.e. spectrum identifications) reported across all analyses (original submission and reanalyses) associated with this dataset.

"N/A" means no results of this type were submitted.
Number of distinct proteins quantified across all analyses (original submission and reanalyses) associated with this dataset.

Distinct protein accessions are counted across all files submitted in the "Statistical Analysis of Quantified Analytes" category having a "Protein" column in this dataset.

"N/A" means no results of this type were submitted.
Number of distinct proteins found to be differentially abundant in at least one comparison across all analyses (original submission and reanalyses) associated with this dataset.

A protein is differentially abundant if its change in abundance across conditions is found to be statistically significant with an adjusted p-value <= 0.05 and lists no issues associated with statistical tests for differential abundance.

Distinct protein accessions are counted across all files submitted in the "Statistical Analysis of Quantified Analytes" category having a "Protein" column in this dataset.

"N/A" means no results of this type were submitted.
This dataset may not contain all raw spectra data as originally deposited in PRIDE. It has been imported to MassIVE for reanalysis purposes, so its spectra data here may consist solely of processed peak lists suitable for reanalysis with most software.